Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary

Timothy D Kinnaird1, Eugenio Stabile, Gary S Mintz

  • 1Cardiovascular Research Institute and Cardiac Catheterization Laboratory, Washington Hospital Center, Washington, DC 20010, USA. tim.kinnaird@medstar.net

Insights

Major bleeding after percutaneous coronary intervention (PCI) affects 5.4% of patients, increasing mortality risk. Predictors include intra-aortic balloon pump use, hypotension, and advanced age, highlighting high-risk patient groups.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Bleeding is a frequent complication of percutaneous coronary intervention (PCI).
  • Understanding the incidence, predictors, and outcomes of bleeding is crucial for patient management.
  • Thrombolysis In Myocardial Infarction (TIMI) criteria are standard for bleeding classification.

Purpose of the Study:

  • To investigate the incidence, predictors, and prognostic impact of periprocedural bleeding and transfusion in patients undergoing PCI.
  • To identify patient and procedural factors associated with major bleeding.
  • To assess the impact of bleeding on in-hospital and long-term mortality.

Main Methods:

  • Retrospective analysis of 10,974 patients who underwent PCI.
  • Classification of bleeding events into major, minor, and no bleeding based on TIMI criteria and hematocrit changes.
  • Multivariate logistic regression to identify predictors of major bleeding.

Main Results:

  • Major bleeding occurred in 5.4% of patients, minor bleeding in 12.7%, and no bleeding in 81.9%.
  • Patients with major bleeding were older and more likely to experience intraprocedural complications like intra-aortic balloon pump use.
  • Strongest predictors for major bleeding included intra-aortic balloon pump use (OR 3.0), procedural hypotension (OR 2.9), and age >80 years (OR 1.9).
  • Major bleeding was independently associated with higher in-hospital and 1-year mortality.

Conclusions:

  • Periprocedural major bleeding is a common complication of PCI with significant adverse prognostic implications.
  • Patients over 80 years old with intraprocedural complications face a particularly high risk of major bleeding.
  • Effective risk stratification and management strategies are needed to mitigate bleeding complications and improve outcomes after PCI.

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...